This cookie is set by GDPR Cookie Consent plugin. The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". The cookie is used to store the user consent for the cookies in the category "Analytics".
These cookies ensure basic functionalities and security features of the website, anonymously. Necessary cookies are absolutely essential for the website to function properly. Their existing partners include Babylon, Leva Clinic, SkinDoc, Syrona Health, and The Dermatology Partnership. The company’s second product, Phlo Connect, provides a seamless, complete digital pharmacy service that healthtech companies and private healthcare providers can use. It has delivered over 110,000 orders since the platform was launched in 2020 and users are more than doubling each year. As of this year, it is launching in Manchester. The company’s flagship product, Digital Pharmacy, offers same-day NHS and private prescription delivery services in Birmingham and London. Similar to Deliveroo, Phlo is a digital pharmacy that provides secure, real-time, same-day delivery of NHS and private prescriptions when and where you need them. It is at the forefront of innovation and product development in the UK pharmacy sector. With Scottish Enterprise investment, the company can scale up operations and expand its services into new markets.” Digitisation of patient care and pharmacyįounded by entrepreneur Nadeem Sarwar in 2019 and headquartered in Glasgow, Scotland, Phlo has a team of over 70. Kerry Sharp, Director of Entrepreneurship and Investment at Scottish Enterprise, said, “Phlo is a fantastic example of a growing innovative company that is helping patients and healthcare providers through its technology. Mark Bamforth, Founder of Thairm Bio, commented, “Thairm Bio is delighted to lead this investment round, in partnership with a dedicated group of investors, and to support Phlo in their continued expansion across the UK.”
We have a very busy roadmap ahead and some incredibly exciting opportunities to take advantage of in 2023 and beyond”. Nadeem Sarwar, Founder and CEO of Phlo, commented, “This round of investment is particularly crucial in helping us scale our offering and realising our vision of establishing Phlo as the market leader in the delivery of next-generation digital pharmacy services right across the UK. It will help the company enable more clinicians and patients to access the benefits of digitised pharmacy services.
The company will use the fresh funds to expand the reach of Phlo Digital Pharmacy, the first UK digital pharmacy to offer patients same-day medication delivery, and to scale Phlo Connect, the market-leading digital infrastructure platform for healthcare providers.įurthermore, the investment will support the scaleup of Phlo’s operations and its partnerships with healthcare providers. It follows the £2 million round raised by Phlo in 2020, which marked the third largest healthtech Crowdfunding campaign in Europe. This investment round is a combination of equity investment and the conversion of existing loan notes. The investment round was led by the family office Thairm Bio, a Trust that invests in early-stage life science companies, which backed PneumoWave.
#Phlo digital pharmacy series
Blockchain-based gaming studio MYSTiC GAMES scores $1.3M to develop Web3-integrated mobile games - TFNĪt this point in time, Phlo, a Scottish digital pharmacy tech startup that offers patients same-day medication delivery has snapped £10 million in Series A funding.
0 kommentar(er)
